Leonard Saltz Selected Research

Leonard Saltz Research Topics

Disease

44	Colorectal Neoplasms (Colorectal Cancer) 12/2024 - 03/2004
44	Neoplasms (Cancer) 02/2024 - 04/2002
21	Rectal Neoplasms (Rectal Cancer) 12/2023 - 07/2002
14	Colonic Neoplasms (Colon Cancer) 12/2024 - 10/2002
11	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2003
5	Adenocarcinoma 03/2006 - 03/2004
4	Carcinoma (Carcinomatosis) 01/2023 - 08/2003
4	Neutropenia 01/2021 - 04/2002
4	Exanthema (Rash) 10/2009 - 05/2005
3	Disease Progression 02/2024 - 01/2011
3	Fatigue 01/2023 - 05/2005
3	Diarrhea 01/2023 - 05/2005
2	Residual Neoplasm 12/2024 - 11/2004
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023 - 01/2019
2	Nausea 01/2023 - 01/2021
2	Vomiting 01/2023 - 01/2021
2	Microsatellite Instability 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 12/2017 - 12/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2013 - 01/2011
1	Sarcoidosis (Schaumann Disease) 02/2024
1	Inflammation (Inflammations) 02/2024
1	Deglutition Disorders (Dysphagia) 01/2023
1	Mucositis 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Edema (Dropsy) 01/2023
1	Constipation 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Pain (Aches) 01/2022
1	COVID-19 01/2021
1	Leukopenia 01/2021
1	Infections 01/2021
1	Cholangiocarcinoma 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Hypoxia (Hypoxemia) 01/2015

Drug/Important Bio-Agent (IBA)

12	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2004
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2003
10	Cetuximab (Erbitux)FDA Link 06/2012 - 08/2005
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2003
8	Bevacizumab (Avastin)FDA Link 12/2018 - 07/2008
7	Biomarkers (Surrogate Marker)IBA 12/2024 - 05/2005
6	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2005
4	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2019
4	Leucovorin (Folinic Acid)FDA Link 02/2013 - 07/2004
3	DNA (Deoxyribonucleic Acid)IBA 12/2024 - 01/2017
3	Carcinoembryonic AntigenIBA 03/2018 - 07/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2017 - 03/2016
2	Trinitrotoluene (TNT)IBA 01/2022 - 04/2019
2	Calcibiotic Root Canal SealerIBA 01/2020 - 01/2019
2	Floxuridine (FUdR)FDA LinkGeneric 01/2020 - 02/2013
2	Angiogenesis InhibitorsIBA 01/2019 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2019 - 03/2016
2	VemurafenibIBA 04/2018 - 12/2015
2	BilirubinIBA 01/2018 - 05/2005
2	MicroRNAs (MicroRNA)IBA 03/2017 - 01/2015
2	Panitumumab (Vectibix)FDA Link 06/2011 - 07/2008
2	Growth Factor ReceptorsIBA 10/2005 - 08/2005
2	alvocidib (flavopiridol)IBA 05/2005 - 04/2002
1	Tumor Biomarkers (Tumor Markers)IBA 02/2024
1	pembrolizumabIBA 02/2024
1	lanreotide (Somatuline)FDA Link 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Gemcitabine FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Unsaturated FatsIBA 10/2018
1	Dietary Fats (Dietary Fat)IBA 10/2018
1	FatsIBA 10/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2018
1	1- (3- (1- methyl- 1H- pyrazol- 4- yl)- 5- oxo- 5H- benzo(4,5)cyclohepta(1,2- b)pyridin- 7- yl)- N- (pyridin- 2- ylmethyl)methanesulfonamideIBA 10/2018
1	AlbuminsIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	LigandsIBA 01/2018
1	Sodium Glutamate (Accent)IBA 11/2016
1	EnzymesIBA 02/2016
1	Oxygen (Dioxygen)IBA 02/2016
1	Glutathione (Reduced Glutathione)IBA 02/2016
1	AntioxidantsIBA 02/2016
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	APTO-253IBA 10/2015
1	Phosphocreatine (Neoton)IBA 01/2015
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2013

Therapy/Procedure

42	Therapeutics 02/2024 - 07/2002
27	Drug Therapy (Chemotherapy) 02/2021 - 07/2002
11	Neoadjuvant Therapy 12/2023 - 12/2005
8	Combined Modality Therapy 07/2012 - 01/2003
7	Radiotherapy 10/2022 - 03/2004
6	Adjuvant Chemotherapy 12/2024 - 10/2002
4	Proctectomy 05/2010 - 01/2003
3	Immunotherapy 02/2024 - 01/2019
2	Induction Chemotherapy 01/2022 - 04/2019
1	Aftercare (After-Treatment) 01/2023
1	Injections 01/2022
1	Colectomy 10/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Hepatectomy 03/2017
1	Ovariectomy (Oophorectomy) 01/2017
1	Continuity of Patient Care 07/2014